Follow The Filings

CURX Curanex Pharmaceuticals

Curanex Pharmaceuticals earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01
8-K 8.01
8-K 3.03,5.03,9.01
10-Q
10-Q
8-K 7.01,9.01
8-K 8.01
8-K 7.01,9.01
10-K
8-K 1.01,5.02,9.01
8-K 5.02,9.01
10-Q
8-K 3.01
8-K 3.02,8.01,9.01
8-K 8.01,9.01
10-Q
8-K 8.01,9.01
8-K 1.01,8.01,9.01
424B4
424B4
S-1/A
S-1/A
S-1/A —
S-1/A —
S-1/A —

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
3 Period Aug 25, 2025 (5 forms)

3 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.